Jiang ZQ, IJRBOP 2012; 83: 332-339
Long term clinical outcomes of IMRT in NSCLC
Update of the MD Anderson experience: 165 patients 2005-2006
66Gy in 33fx
Median survival 21.6 months
Esophageal Tox G3
G2: 70%
G3: 18% - 7/29 stricture
Lung Tox G3: 11% 6m;
14% 12m
Lung Tox G2
Lung Tox G1: at 18m
86%